The possible mechanisms of action of (-)deprenyl in Parkinson's disease.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism; D001692:Biological Transport / Q000187:drug effects; D002415:Cats; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008995:Monoamine Oxidase / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D010627:Phenethylamines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012642:Selegiline / Q000494:pharmacology* / Q000627:therapeutic use
D001679:Biogenic Amines; D010627:Phenethylamines; D012642:Selegiline; D007980:Levodopa; D008995:Monoamine Oxidase; D000109:Acetylcholine